Cargando…

Enhanced-Dose Statins for ST-Segment Elevation Myocardial Infarction Patients after Emergency Percutaneous Coronary Intervention

BACKGROUND: Acute ST-segment elevation myocardial infarction (STEMI) is a serious multiple acute cardiovascular disease. This study investigated the effect of statins on the efficacy and prognosis of STEMI patients after emergency PCI. METHODS: From October 2019 to January 2021, 98 patients with STE...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenzhong, Fan, Zhiwen, Huang, Canhui, Han, Zhiyuan, Liu, Junying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256331/
https://www.ncbi.nlm.nih.gov/pubmed/35801005
http://dx.doi.org/10.1155/2022/2751750
_version_ 1784741086973919232
author Chen, Wenzhong
Fan, Zhiwen
Huang, Canhui
Han, Zhiyuan
Liu, Junying
author_facet Chen, Wenzhong
Fan, Zhiwen
Huang, Canhui
Han, Zhiyuan
Liu, Junying
author_sort Chen, Wenzhong
collection PubMed
description BACKGROUND: Acute ST-segment elevation myocardial infarction (STEMI) is a serious multiple acute cardiovascular disease. This study investigated the effect of statins on the efficacy and prognosis of STEMI patients after emergency PCI. METHODS: From October 2019 to January 2021, 98 patients with STEMI in our hospital were selected and divided into study group and control group. The study group took atorvastatin 40 mg 2 hours before surgery, 40 mg/day after surgery, and 20 mg/day 1 week later. The control group received 20 mg of atorvastatin every night after admission. The cardiac output, left ventricular ejection fraction, blood flow classification, vagus nerve function, heart rate deceleration force and chemoreflex sensitivity were compared between the two groups, and recorded the incidence of adverse reactions before and after treatment and 3 months after treatment. The number of major adverse cardiac events (MACEs) was also recorded. RESULTS: Before treatment, there were no differences in CO, CI, and LVEF between the study and control groups. After treatment, CO, CI, and LVEF in the study group were significantly higher than those in the control group. Before treatment, there was no significant difference in TIMI blood flow classification among the groups, and after treatment, the study group was better than the control group. DC and ChRS were significantly higher in the study group than in the control group. There was no difference in the incidence of adverse reactions between the study group and the control group. However, the incidence of MACE in the study group was lower than that in the control group. CONCLUSION: Enhanced-dose atorvastatin for STEMI patients improved PCI treatment effect, cardiac function, and vagus nerve function and reduced the incidence of adverse cardiac events. Thus, statins are safe and worth considering.
format Online
Article
Text
id pubmed-9256331
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-92563312022-07-06 Enhanced-Dose Statins for ST-Segment Elevation Myocardial Infarction Patients after Emergency Percutaneous Coronary Intervention Chen, Wenzhong Fan, Zhiwen Huang, Canhui Han, Zhiyuan Liu, Junying Dis Markers Research Article BACKGROUND: Acute ST-segment elevation myocardial infarction (STEMI) is a serious multiple acute cardiovascular disease. This study investigated the effect of statins on the efficacy and prognosis of STEMI patients after emergency PCI. METHODS: From October 2019 to January 2021, 98 patients with STEMI in our hospital were selected and divided into study group and control group. The study group took atorvastatin 40 mg 2 hours before surgery, 40 mg/day after surgery, and 20 mg/day 1 week later. The control group received 20 mg of atorvastatin every night after admission. The cardiac output, left ventricular ejection fraction, blood flow classification, vagus nerve function, heart rate deceleration force and chemoreflex sensitivity were compared between the two groups, and recorded the incidence of adverse reactions before and after treatment and 3 months after treatment. The number of major adverse cardiac events (MACEs) was also recorded. RESULTS: Before treatment, there were no differences in CO, CI, and LVEF between the study and control groups. After treatment, CO, CI, and LVEF in the study group were significantly higher than those in the control group. Before treatment, there was no significant difference in TIMI blood flow classification among the groups, and after treatment, the study group was better than the control group. DC and ChRS were significantly higher in the study group than in the control group. There was no difference in the incidence of adverse reactions between the study group and the control group. However, the incidence of MACE in the study group was lower than that in the control group. CONCLUSION: Enhanced-dose atorvastatin for STEMI patients improved PCI treatment effect, cardiac function, and vagus nerve function and reduced the incidence of adverse cardiac events. Thus, statins are safe and worth considering. Hindawi 2022-06-28 /pmc/articles/PMC9256331/ /pubmed/35801005 http://dx.doi.org/10.1155/2022/2751750 Text en Copyright © 2022 Wenzhong Chen et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chen, Wenzhong
Fan, Zhiwen
Huang, Canhui
Han, Zhiyuan
Liu, Junying
Enhanced-Dose Statins for ST-Segment Elevation Myocardial Infarction Patients after Emergency Percutaneous Coronary Intervention
title Enhanced-Dose Statins for ST-Segment Elevation Myocardial Infarction Patients after Emergency Percutaneous Coronary Intervention
title_full Enhanced-Dose Statins for ST-Segment Elevation Myocardial Infarction Patients after Emergency Percutaneous Coronary Intervention
title_fullStr Enhanced-Dose Statins for ST-Segment Elevation Myocardial Infarction Patients after Emergency Percutaneous Coronary Intervention
title_full_unstemmed Enhanced-Dose Statins for ST-Segment Elevation Myocardial Infarction Patients after Emergency Percutaneous Coronary Intervention
title_short Enhanced-Dose Statins for ST-Segment Elevation Myocardial Infarction Patients after Emergency Percutaneous Coronary Intervention
title_sort enhanced-dose statins for st-segment elevation myocardial infarction patients after emergency percutaneous coronary intervention
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256331/
https://www.ncbi.nlm.nih.gov/pubmed/35801005
http://dx.doi.org/10.1155/2022/2751750
work_keys_str_mv AT chenwenzhong enhanceddosestatinsforstsegmentelevationmyocardialinfarctionpatientsafteremergencypercutaneouscoronaryintervention
AT fanzhiwen enhanceddosestatinsforstsegmentelevationmyocardialinfarctionpatientsafteremergencypercutaneouscoronaryintervention
AT huangcanhui enhanceddosestatinsforstsegmentelevationmyocardialinfarctionpatientsafteremergencypercutaneouscoronaryintervention
AT hanzhiyuan enhanceddosestatinsforstsegmentelevationmyocardialinfarctionpatientsafteremergencypercutaneouscoronaryintervention
AT liujunying enhanceddosestatinsforstsegmentelevationmyocardialinfarctionpatientsafteremergencypercutaneouscoronaryintervention